[Dynamics of cognitive impairments during L-dopa therapy in Parkinson's disease].
- 2021
- RCT · n = 41
- Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121(7)
- S B Ismailova
- S V Prokopenko
- D V Pokhabov
- E I Mosaleva
- P V Alekseenko
- I M Zhumzhanov
- PubMed: 34460155
- DOI: 10.17116/jnevro202112107136
- High evidence
- Clinical
The statistically significant improvement of CF at the «peak» of levodopa drugs ... the most dependent on L-DOPA therapy CF were attention, speech, executive and visual-spatial functions.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes